MapLight Therapeutics, Inc. (MPLT)
7.25
+0.18
(+2.55%)
USD |
NASDAQ |
Nov 13, 16:00
7.25
0.00 (0.00%)
After-Hours: 19:59
MapLight Therapeutics Total Liabilities (Quarterly) : 20.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.05M |
| March 31, 2026 | 18.95M |
| December 31, 2025 | 21.14M |
| September 30, 2025 | 23.71M |
| Date | Value |
|---|---|
| June 30, 2025 | 20.36M |
| March 31, 2025 | 18.57M |
| June 30, 2024 | |
| March 31, 2024 | 19.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 13.34M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.637B |
| Anixa Biosciences, Inc. | 1.873M |
| Vicapsys Life Sciences, Inc. | 3.682M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.35M |
| Shareholders Equity (Quarterly) | 348.30M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |